US Patent 10065956 Ethynyl derivatives
All edits
Edits on 13 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+311 characters)
Article
Patent abstract
The present invention relates to compounds that may be used for the treatment of Parkinson's disease, anxiety, emesis, obsessive compulsive disorder, autism, neuroprotection, cancer, depression and diabetes type 2. Compounds of formula I are representative, where substituents are defined herein:
Edits on 2 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
100659560
Date of Patent
September 4, 2018
0Patent Application Number
157078480
Date Filed
September 18, 2017
0Patent Citations Received
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
100659560
Date of Patent
September 4, 2018
0Patent Application Number
157078480
Date Filed
September 18, 2017
0Patent Citations Received
Patent Primary Examiner
Edits on 12 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 9 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 22 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 10065956 Ethynyl derivatives
Infobox
Is a
Patent jurisdiction
Patent number
10065956
Date of patent
September 4, 2018
Patent application number
15707848
Date Filed
September 18, 2017
Patent primary examiner
Find more entities like US Patent 10065956 Ethynyl derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
